These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32154156)

  • 61. Inhibition of microRNA-128-3p attenuates hypercholesterolemia in mouse model.
    Chandra A; Sharma K; Pratap K; Singh V; Saini N
    Life Sci; 2021 Jan; 264():118633. PubMed ID: 33190783
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Therapeutic targets of hypercholesterolemia: HMGCR and LDLR.
    Ma S; Sun W; Gao L; Liu S
    Diabetes Metab Syndr Obes; 2019; 12():1543-1553. PubMed ID: 31686875
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of cholesterol synthesis in rat adrenal gland through coordinate control of 3-hydroxy-3-methylglutaryl coenzyme A synthase and reductase activities.
    Balasubramaniam S; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1421-5. PubMed ID: 16260
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy: A Case Report.
    Tokunaga Y; Akiyama M; Nakano K; Konaka K; Taguchi A; Maeda T; Sato R; Kanda T; Nakamura Y; Yujiri T; Ohta Y
    Intern Med; 2024 Jul; ():. PubMed ID: 38987186
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on the induction of low-density lipoprotein receptor in HepG2 cells.
    Hayashi K; Kurokawa J; Nomura S; Kuga Y; Ohkura Y; Kajiyama G
    Biochim Biophys Acta; 1993 Apr; 1167(2):223-5. PubMed ID: 8466953
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Degradation versus Inhibition: Development of Proteolysis-Targeting Chimeras for Overcoming Statin-Induced Compensatory Upregulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase.
    Li MX; Yang Y; Zhao Q; Wu Y; Song L; Yang H; He M; Gao H; Song BL; Luo J; Rao Y
    J Med Chem; 2020 May; 63(9):4908-4928. PubMed ID: 32321253
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Electroacupuncture mitigates hyperlipidemia via improving cholesterol metabolism mediated by SCAP/SREBP-2 signaling in liver tissue in rats].
    Wu H; Zhang ZQ; Chen L; Liao S; Wang XF; Lin W
    Zhen Ci Yan Jiu; 2023 Apr; 48(4):325-30. PubMed ID: 37186195
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption.
    Plat J; Mensink RP
    Eur J Clin Invest; 2002 Apr; 32(4):242-50. PubMed ID: 11952809
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    Azemi NA; Azemi AK; Abu-Bakar L; Sevakumaran V; Muhammad TST; Ismail N
    Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547909
    [No Abstract]   [Full Text] [Related]  

  • 71. Analysis of endocrine disruption effect of Roundup
    Pandey A; Rudraiah M
    Toxicol Rep; 2015; 2():1075-1085. PubMed ID: 28962449
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synergetic cholesterol-lowering effects of main alkaloids from Rhizoma Coptidis in HepG2 cells and hypercholesterolemia hamsters.
    Kou S; Han B; Wang Y; Huang T; He K; Han Y; Zhou X; Ye X; Li X
    Life Sci; 2016 Apr; 151():50-60. PubMed ID: 26876917
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bisphenol A induces cholesterol biosynthesis in HepG2 cells via SREBP-2/HMGCR signaling pathway.
    Li Q; Zhang H; Zou J; Feng X; Feng D
    J Toxicol Sci; 2019; 44(7):481-491. PubMed ID: 31270304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice.
    Xu Y; Li F; Zhao X; Tan C; Wang B; Chen Y; Cao J; Wu D; Yu H
    FASEB J; 2020 Mar; 34(3):3805-3819. PubMed ID: 31975555
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HMG-CoA reductase degrader, SR-12813, counteracts statin-induced upregulation of HMG-CoA reductase and augments the anticancer effect of atorvastatin.
    Zhou Y; Tashiro J; Kamatani S; Irie N; Suzuki A; Ishikawa T; Warita K; Oltvai ZN; Warita T
    Biochem Biophys Res Commun; 2023 Oct; 677():13-19. PubMed ID: 37541087
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Citrus junos Tanaka peel ameliorates hepatic lipid accumulation in HepG2 cells and in mice fed a high-cholesterol diet.
    Shin EJ; Park JH; Sung MJ; Chung MY; Hwang JT
    BMC Complement Altern Med; 2016 Dec; 16(1):499. PubMed ID: 27912736
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus.
    Stormo C; Kringen MK; Grimholt RM; Berg JP; Piehler AP
    BMC Mol Biol; 2012 Sep; 13():29. PubMed ID: 22989091
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A long distance dispersal hypothesis for the Pandanaceae and the origins of the Pandanus tectorius complex.
    Gallaher T; Callmander MW; Buerki S; Keeley SC
    Mol Phylogenet Evol; 2015 Feb; 83():20-32. PubMed ID: 25463018
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse peritoneal macrophages.
    Angelin B
    Biochem J; 1988 Oct; 255(2):529-34. PubMed ID: 3202831
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
    Tobert JA; Bell GD; Birtwell J; James I; Kukovetz WR; Pryor JS; Buntinx A; Holmes IB; Chao YS; Bolognese JA
    J Clin Invest; 1982 Apr; 69(4):913-9. PubMed ID: 6918402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.